IL-15 and IL-15R\alpha sushi domain based immunocytokines
Sebastien Daniel Morisseau, Donges (FR); Geraldine Teppaz, Nantes (FR); Yannick Laurent Joseph Jacques, Nantes (FR); Bruno Gilbert Marc Robert, Valflaunes (FR); Guy Luc Michel De Martynoff, Mont-St-Guibert (BE); and David Bechard, Saint-Etienne de Montluc (FR)
Assigned to Cytune Pharma, Nantes (FR); and INSERM (Institut National de la Santé et de la Recherche Médicale), Paris (FR)
Filed by Cytune Pharma, Nantes (FR); and INSERM (Institut National De La Santé Et De La Recherche Medicale), Paris (FR)
Filed on Oct. 12, 2020, as Appl. No. 17/68,628.
Application 17/068,628 is a division of application No. 16/012,174, filed on Jun. 19, 2018, granted, now 10,899,816.
Application 16/012,174 is a continuation of application No. 15/214,032, filed on Jul. 19, 2016, granted, now 10,626,155, issued on Apr. 21, 2020.
Application 15/214,032 is a continuation of application No. 14/129,188, abandoned, previously published as PCT/EP2012/002650, filed on Jun. 22, 2012.
Claims priority of application No. 1358005 (EP), filed on Jun. 24, 2011.
Prior Publication US 2021/0147503 A1, May 20, 2021